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Abstract
Background: We assessed the potential of multilocus variable-number tandem-repeat analysis (MLVA), pulsed-field
gel electrophoresis (PFGE), and antimicrobial susceptibility testing for discriminating 104 sporadic and outbreak-
related Yersinia enterocolitica (YE) bio/serotype 3-4/O:3 and 2/O:9 isolates. MLVA using six VNTR markers was
performed in two separate multiplex PCRs, and the fluorescently labeled PCR products were accurately sized on an
automated DNA sequencer.
Results: MLVA discriminated 82 sporadic YE 3-4/O:3 and 2/O:9 strains into 77 types, whereas PFGE with the
restriction enzyme NotI discriminated the strains into 23 different PFGE pulsotypes. The discriminatory index for a
sporadic strain was 0.862 for PFGE and 0.999 for MLVA. MLVA confirmed that a foodborne outbreak in the city of
Kotka, Finland in 2003 had been caused by a multiresistant YE 4/O:3 strain that was distinctly different from those
of epidemiologically unrelated strains with an identical PFGE pulsotype. The multiresistance of Y. enterocolitica
strains (19% of the sporadic strains) correlated significantly (p = 0.002) with travel abroad. All of the multiresistant
Y. enterocolitica strains belonged to four PFGE pulsotypes that did not contain any susceptible strains. Resistance to
nalidixic acid was related to changes in codons 83 or 87 that stemmed from mutations in the gyrA gene. The
conjugation experiments demonstrated that resistance to CHL, STR, and SUL was carried by a conjugative plasmid.
Conclusions: MLVA using six loci had better discriminatory power than PFGE with the NotI enzyme. MLVA was
also a less labor-intensive method than PFGE and the results were easier to analyze. The conjugation experiments
demonstrated that a resistance plasmid can easily be transferred between Y. enterocolitica strains. Antimicrobial
multiresistance of Y. enterocolitica strains was significantly associated with travel abroad.
Background
Yersinia enterocolitica (YE) is an enteropathogenic bac-
terium transmitted via food or water and may cause
sporadic infections as well as foodborne outbreaks of
yersiniosis [1-5]. The symptoms of yersiniosis range
from mild diarrhea to severe clinical manifestations and
post-infectious complications such as reactive arthritis,
myocarditis, glomerulonephritis, and erythema nodosum
[6]. Y. enterocolitica can be divided into six biotypes, of
which biotypes 1B and 2-5 are known to be pathogenic
to humans.
At present, pulsed-field gel electrophoresis (PFGE) is
commonly used to discriminate between Y. enterocoli-
tica strains. However, there are no standard PFGE pro-
cedures or databases similar to those, e.g., for
Escherichia coli O157:H7, Salmonella, and Shigella stan-
dardized by PulseNet [7]. Most of the restriction
enzymes used in PFGE for Y. enterocolitica produce pat-
terns with a high number of bands that are not ideal for
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analysis. Furthermore, the global homogeneity of the
pulsotypes among Y. enterocolitica 4/O:3 is high and dif-
ferent pulsotypes often display only minor differences
[8-11]. However, the discriminatory power of PFGE has
been improved by using more than one restriction
enzyme [12].
Most bacterial genomes contain repeats of DNA
sequences called “variable-number tandem repeats”
(VNTR). These VNTR regions can be applied in the
PCR-based subtyping of strains by multilocus variable-
number tandem-repeat analysis (MLVA). MLVA is
increasingly used for typing, surveillance and epidemio-
logical investigations of pathogenic bacteria [13].
A study investigating the development of an MLVA sub-
typing method to be used for Y. enterocolitica 4/O:3,
based on six loci, was reported recently [14].
Although yersiniosis is seldom treated with antimicro-
bials, medication may be required, for example in the
case of immuno-compromised patients. Y. enterocolitica
is a known ß-lactamase producer and thus is resistant
to ß-lactam antibiotics such as ampicillin, carbenicillin,
penicillin, and first-generation cephalosporins [15-20].
In recent studies done in Switzerland, the USA,
Germany, and Austria, Y. enterocolitica strains have
shown high susceptibility to antimicrobials other than
ß-lactams [21-24]. However, multiresistant Y. enterocoli-
tica strains have also been reported, e.g., from Spain and
Brazil [16,25,26]. The antimicrobial resistance of
Y. enterocolitica has not been monitored regularly in
Finland although the surveillance of antimicrobial resis-
tance would be useful for epidemiological studies. Over
20 years ago, 186 Finnish Y. enterocolitica strains were
studied and found to be resistant only to ampicillin
and susceptible to ceftriaxone, tetracycline, sulpha-
trimethoprim, and ciprofloxacin [27].
The aim of the present study was to determine how
MLVA using fluorescently labeled primers and fragment
analysis compares to PFGE in its discriminatory power
with regard to the sporadic and outbreak-related strains
of YE bio/serotypes 4/O:3. We included traditional anti-
microbial susceptibility testing in our study to see
whether it provides additional information for the geno-
typic analysis concerning, e.g., the geographical source of
infection. We therefore used MLVA and PFGE to type
104 sporadic and outbreak-associated Y. enterocolitica
strains and determined the sensitivity of the strains to 12
antimicrobial agents. In addition, we studied the genetic
basis of the antimicrobial resistance that was detected.
Results
Sporadic strains
The strains isolated in 2006 (n = 82) were discriminated
into 77 types by MLVA (Figure 1) and into 23 pulsotypes
by PFGE (Figure 2). There were two YE 4/O:3 strains
with identical MLVA types in only five cases. In two of
these cases, the identical strains had been isolated from
one patient 7 days apart and from another patient
19 days apart. The discriminatory index for sporadic
strains was 0.862 for PFGE and 0.999 for MLVA.
The six loci used in MLVA V2A exhibited the highest
discriminatory power (DI = 92%), resolving 17 different
alleles. The least variation was observed for locus V9
(DI = 62%), which yielded only six different alleles, i.e.,
2-7 repeats of a repetitive sequence 12 bp in length. The
discriminatory indexes of loci V4, V5, V6, and V7 were
71, 89, 91, and 90%, respectively. The fragment sizes
defined by the capillary electrophoresis of the six VNTR
loci and the number of repeats confirmed by DNA
sequencing are shown in Table 1.
Suspected outbreak strains
The suspected outbreak strains (n = 22) from December
2003 to January 2004 represented four PFGE pulsotypes,
which were further typed into 11 MLVA types. Twelve of
the strains were identical in MLVA type. Eleven of these
strains with identical MLVA types were isolated from the
patients with an epidemiological connection to the disease
outbreak. The 12 strains with identical MLVA type repre-
sented 2 slightly different (only one band difference) PFGE
pulsotypes (Figure 2) and were multiresistant to antimicro-
bials (Figure 1). Among these strains, eleven were resistant
to AMP, CHL, STR SUL, and TET; one strain was suscep-
tible to TET. The suspected outbreak strains with different
MLVA types did not have a proved connection to the city
of Kotka, Finland. Nine of these strains were susceptible to
all the tested antimicrobials except AMP and eight of them
shared the same PFGE type. One of the strains (IH250258)
had an antimicrobial resistance profile and a PFGE pulso-
type identical to those of the outbreak strains. However,
the different MLVA type and the lack of epidemiological
connection distinguished this particular case from the out-
break-associated cases (Figure 2). Suspected YE 4/O:3 out-
break strains isolated in 2006 from six 1-year-old children
displayed the same PFGE pulsotype (5NotI_ye a). However,
the MLVA discriminated all six strains.
Association between the antimicrobial resistance and
travel
All the Y. enterocolitica strains studied here were resistant
to ampicillin. Fifteen (19%) of 80 sporadic strains isolated
in 2006 from 80 patients were resistant to four or five of
the antimicrobials tested (Table 2). The multiresistant
strains belonged to certain PFGE pulsotypes (1NotI_ye,
3NotI_ye, 7NotI_ye, 15NotI_ye) that did not contain any
susceptible strains. The travel history of 70 of the 80
patients was known. Of these patients, 46% (32/70) had
traveled abroad before the onset of symptoms. Travel
abroad was significantly (p = 0.002) associated with the
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Figure 1 MLVA tree. UPGMA clustering of the MLVA results, with Pearson’s correlation similarity coefficients, was performed using Bionumerics
version 5.10. The key column provides the strain ID. Information on bio/serotype, travel abroad or place of domicile (PoD), MLVA types named
as a string of six numbers showing the actual number of repeat units in each of the six loci, PFGE pulsotype, and antimicrobial resistance are
presented in the columns. *Strains isolated from a 1-year old children in the case of a suspected outbreak with PFGE pulsotype 5NotI_ye_a.
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antimicrobial multiresistance of Y. enterocolitica: 34% (11/
32) of the patients with and 5% (2/38) of the patients with-
out a trip abroad had a multiresistant Y. enterocolitica
strain. Three strains resistant to nalidixic acid had
decreased susceptibility (0.25, 0.25, or 0.5 mg/L) to cipro-
floxacin in MIC determination. Sequencing of these three
nalidixic acid resistant strains revealed amino acid changes
due to the point mutations in the gyrA gene; i.e., Ser83 to
Arg or Asp87 to Asn or Asp87 to Tyr.
Conjugation of resistance plasmid
In the conjugation experiment, a sporadic YE 4/O:3
strain FE81008 (resistant to AMP, CHL, STR, SUL, and
NAL) was able to transfer the CHL, STR, and SUL resis-
tances to strain YeO3-U by conjugation. The conjuga-
tion frequency was 10-5-10-6. This indicated that the
genes encoding resistance to CHL, STR, and SUL were
carried on a conjugative plasmid. Indeed, plasmid isola-
tion demonstrated that the recipient strain had received
a large 30-40 kb plasmid.
Discussion
In our study, MLVA typing using fluorescently labeled
primers and fragment analysis was shown to be a high-
resolution discriminatory method for epidemiological
investigations of Y. enterocolitica. In the present study,
Figure 2 PFGE types of the studied strains. All 24 representative PFGE types of 104 strains in the present study. * The strain number includes
the outbreak types.
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the discriminatory power of MLVA was 99.9% while
that of NotI PFGE was 87.9%. Our results were in agree-
ment to those obtained by Gierczyński and colleagues
[14] who demonstrated that the used MLVA markers
are highly discriminatory and added the evidence that
this method can successfully be applied for the outbreak
strains of Y. enterocolitica ssp. palearctica biotypes 2
and 4. In the present study, only the VNTR loci V2A,
V4 and V5 were found in six BT 1A strains tested with
the MLVA method (data not shown). Another MLVA
method designed using Y. enterocolitica ssp. enterocoli-
tica strain 8081 whole genome and with four loci was
introduced recently [28]. The method showed potential
for the epidemiological investigation for YE biotype 1A
strains with DI of 87% and worked also for six tested
BT 2 and BT4 strains [28]. The discriminatory power of
Table 1 Diversity of VNTR alleles
Number of the
repeats
V2A TCTCAC
(bp)
n† V4 CGGCAAC
(bp)
n V5 GGTGCA
(bp)
n V6 GACTCA
(bp)
n V7 GTGCTG
(bp)
n V9
ATGTCGGTAGAA
(bp)
n
2 - 119* 49 - - 108 2
3 246* 2 126* 26 182 1 - 120* 52
4 252 5 133* 9 199 2 188* 5 195* 4 132 8
5 258 6 140 0 205 4 194 5 201* 8 144* 40
6 264 10 147 15 211 3 200* 11 207 19 156 2
7 270 6 154* 4 217 6 206* 21 213 13 168* 3
8 276 6 161 4 223* 25 212* 13 219 12 -
9 282* 7 - 229 17 218 2 225 9 -
10 288 10 - 235 15 224 12 231 9 -
11 294 6 - 241 8 230 9 237 7 -
12 300 10 - 247 6 236 10 243 1 -
13 306 20 - 253 6 242 4 249 4 -
14 312 4 - 259 5 248 2 255* 16 -
15 318 3 - 265* 5 254 3 261 3 -
16 324 1 - 271 3 260 3 267 - -
17 330* 7 - 277 1 266 2 273 - -
18 336 3 - 283 - 272 - 279 - -
19 342 1 - 290 1 278 - 285 - -
20 - - - 284 2 291 1 -
21 - - - 300 2 297 - -
22 - - - 303* 1 -
Fragment sizes (bp) defined by capillary electrophoresis of VNTR alleles with different number of repeats and their diversity in 107 studied Y. enterocolitica
strains.
* Alleles were sequenced to confirm the number of repeats.
† n = number of strains.
Table 2 Antimicrobial resistance and travelling
Resistance profile Suspected outbreak YE 4/O:3
(n = 22)
Sporadic YE 4/O:3
(n = 75)
Sporadic YE 3/O:3
(n = 2)
Sporadic YE 2/O:9
(n = 5)
AMP CHL STR SUL NAL - 3 (100%)* - -
AMP CHL STR SUL TET 12 (0%) 5 (40%) - -
AMP CHL STR SUL TET
MEC
- - 1 (100%) -
AMP CHL STR SUL 1 (0%) 5 (80%) - -
AMP CHL STR SUL MEC - - 1 (100%) -
AMP SUL - 1 (100%) - -
AMP STR - 1 - -
AMP MEC - - - -
AMP 9 (0%) 61 (28%) - 5 (0%)
Antimicrobial resistance profiles of the sporadic Y. enterocolitica strains isolated in Finland in 2006 and suspected outbreak strains from 2003-2004 and related
travel information.
* The percentage of the patients who had reported having traveled abroad before getting ill is in the parenthesis.
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PFGE can be improved by using more than one restric-
tion enzyme. For instance, the discriminatory index of
74% achieved with NotI PFGE was increased to 93% by
using further characterization with ApaI and XhoI
enzymes of 128 YE 4/O:3 strains [29]. However, both
the time required and the costs of PFGE rise consider-
ably when several restriction enzymes are used. The
amount of working time needed for the PFGE protocol
with one enzyme is two to three days, MLVA using
fragment analysis can be done in one day.
In December 2003, authorities from the city of Kotka,
Finland reported an outbreak of gastroenteritis. Investi-
gations revealed that it was caused by Y. enterocolitica
4/O:3 [30]. Approximately 30 people fell ill; 12 patients
had culture-confirmed, multiresistant YE 4/O:3 infec-
tion. Three of them had appendectomies before the dis-
ease was recognized as yersiniosis. Most of the patients
had abdominal pain (94%), fever (78%), and diarrhea
(72%). Most of the patients had eaten in the same cafe-
teria in the Port of Kotka between November 25 and
December 15, 2003. However, the contaminated food
source was not discovered, as the food served in that
cafeteria was no longer available for microbiological
investigations. In addition, a cohort study among cafe-
teria users did not show a significant association
between any food and illness. During a microbiological
sampling of the cafeteria’s kitchen a month later, in Jan-
uary 2004, hygienists noticed some shortcomings in
food handling and hygiene practices that increased the
possibility of cross-contamination in the cafeteria. While
no YE 4/O:3 strains were found in the specimens col-
lected from the cafeteria, YE biotype 1A strains were
isolated from iceberg lettuce imported from Spain and
from domestic carrots. Unfortunately, the antimicrobial
susceptibilities of these strains are not known. At the
time of the outbreak in Kotka, there were around 20
confirmed YE 4/O:3 cases in other locations in Finland,
mainly in the Turku area. The cases were suspected to
be linked with the larger outbreak, but no epidemiologi-
cal evidence for this was found.
MLVA played a key role in confirming that the cases
which occurred in the city of Kotka in 2003 belonged to
a single outbreak: 12 isolates representing the Kotka
outbreak were clonal by MLVA, and differed distinctly
from those of epidemiologically unrelated strains that
shared the same PFGE pulsotype. Another suspicion of
outbreak was refuted by MLVA: six 1-year-old children
had been infected in 2006 by YE 4/O:3 strains that
shared the same PFGE pulsotype (5NotI_ye a). Inter-
views, however, revealed no epidemiological connection
between the cases. All of these strains which shared the
same PFGE pulsotype were found to be of different
types in MLVA. We also detected some evidence that
the MLVA method can be as useful with YE 2/O:9
outbreaks as it was with YE 4/O:3. In a household out-
break in 2009, a mother and two children had YE 2/O:9
strains found to be identical in MLVA (data not shown
here). MLVA also identified identical YE 2/O:9 strains
in a school/day care center outbreak that occurred in
Finland in 2010 (data not shown here).
Support was obtained for genetic stability among
sporadic cases, since two MLVA-typed strains were
isolated twice from the same patient at intervals of 7 or
19 days. In both cases, the MLVA and PFGE types
remained identical. Similar observations of the stability
of the Y. enterocolitica MLVA markers’ loci in vivo had
also been reported earlier [14]. Genetic events will even-
tually alter the MLVA patterns, but the rate of alteration
is not known. However, previous studies confirmed that
the MLVA type remained the same after as many as 20
serial passages of colony plating [14].
Our previous case-control study revealed that travel
abroad was a risk factor for Y. enterocolitica infection in
Finland [31]. In the present study, we found a statisti-
cally significant association between the antimicrobial
multiresistance of YE strains and travel. The results
indicate that a considerable number of multiresistant
Y. enterocolitica infections are actually imported, and
that domestic Y. enterocolitica strains in Finland are
rather susceptible to antimicrobials. For instance, all of
the nalidixic acid-resistant strains were isolated from
patients who had been infected while on vacation
in Spain or Brazil, countries where multiresistant
Y. enterocolitica strains have been described previously
[16,25,26]. The multiresistant strains belonged to certain
PFGE pulsotypes, which were not found among suscep-
tible strains. This is perhaps due to the DNA of the
resistance plasmid. The MLVA types were so varied that
no hint of the origin of the strains could be obtained on
that basis.
In the outbreak that occurred in Kotka, the patients
had not been abroad before falling ill. However, the
antimicrobial multiresistance of the outbreak strain
nevertheless suggests that the strain originated from
abroad. Spanish iceberg lettuce, at least, had been used
in the cafeteria. In 2005 Salmonella enterica serotype
Typhimurium, with a resistance profile identical to that
detected now for the Y. enterocolitica outbreak strain,
was isolated in an outbreak situation in Finland and
traced to iceberg lettuce imported from Spain [32].
The resistance of Y. enterocolitica to NAL is based on
point mutations in the fluoroquinolone resistance-
determining regions of gyrA [26,33]. In our study, the
strains resistant to NAL had amino acid changes stem-
ming from point mutations in the gyrA gene: i.e., either
Ser83Arg, Asp87Tyr, or Asp87Asn. Two of these muta-
tions are identical to those reported previously for fluor-
oquinolone-resistant Y. enterocolitica strains [33].
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Conjugation experiments confirmed that in Y.
enterocolitica, the antibiotic resistance to CHL, STR,
and SUL, at least, is encoded on a large conjugative
plasmid and can easily be transferred to a susceptible
Y. enterocolitica strain. Conjugative plasmids that carry
antibiotic resistance genes have been isolated from a
variety of clinical strains, but reports of this for Y. enter-
ocolitica are rare. Hundreds of different antibiotic resis-
tance cassettes have been identified as residing on
mobile resistance integrons [34]; owing to the cassette
nature of the resistance genes, they can easily change
the resistance repertoire. In fact, one of the outbreak
strains in our study had altered antimicrobial resistance
and lacked resistance to TET. A study on the persis-
tence of TET-resistant E. coli in colonic microbiota
observed that three out of 13 strains lost TET resistance
during intestinal colonization [35].
Conclusions
MLVA was less labor-intensive than PFGE and the
results were easier to analyze, especially because they
were independent of subjective interpretation. PFGE
can still be useful for surveillance of the sources and
transmission routes of sporadic Y. enterocolitica
strains in future. However, for outbreak investigations,
MLVA offers a powerful tool for the discrimination of
Y. enterocolitica strains. More sporadic and outbreak
Y. enterocolitica strains should be subjected to MLVA
typing in order to determine whether this method
could be considered for use as a new gold standard
for outbreak investigations of Y. enterocolitica. This
study revealed that multiresistant Y. enterocolitica
strains do appear in Finland, but that the multiresis-
tance was mainly associated with travel. All three nali-
dixic acid resistant strains were associated with travel
to Spain or Brazil. Interestingly, all outbreak strains
studied here were also multiresistant. Thus, traditional
susceptibility testing provides additional information
useful for genetic typing methods in epidemiological
investigations.
Methods
Bacterial strains
Sporadic Y. enterocolitica strains (n = 82) of bio/sero-
type 4/O:3 (n = 75), 3/O:3 (n = 2), 2/O:9 (n = 5) iso-
lated in 2006 from fecal samples of 80 Finnish patients
in ten regional clinical microbiology laboratories were
used in the study. The patients’ mean age was 34 years
(range 0.6-80); 55% of them were men. Isolation and
identification of the strains were described previously
[36]. In addition, 22 clinical Y. enterocolitica strains iso-
lated between December 2003 and January 2004, and
suspected of being associated with a Y. enterocolitica
outbreak in Kotka, were studied.
MLVA
For MLVA, we had three additional reference strains:
NCTC 1176 (4/O:3); NCTC 11174 (2/O:9); and NCTC
10563 (3/O:5,27). DNA was extracted from the strains
using the Jet Flex Extraction Kit (Genomed; Löhne,
Germany) according to the instructions provided by the
manufacturer and eluated in 100 μL TE-buffer. In the
MLVA analysis, six known VNTR loci of the strains were
amplified in two multiplex PCRs. Previously described pri-
mers [14] were labeled with ABI PRISM® fluorescent dyes,
PET, NED, 6-FAM, or VIC (Applied Biosystems, Foster
City, CA). Primers were used in two separate multiplex
PCRs with the VNTR loci of V2A (PET), V4 (NED), and
V6 (6-FAM), as well as V5 (NED), V7 (VIC), and V9
(PET). Multiplex PCRs were performed with QIAGEN
Multiplex PCR kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions in a total volume of 25
μl. The primer concentrations were 0.2 μM (V2A), 0.16
μM (V4), and 0.2 μM (V6) in the first PCR and 0.2 μM
(V5), 0.2 μM (V7), 0.12 μM (V9) in the second PCR. The
template DNA concentration was approx. 10 ng. Touch-
down PCR was performed with 15 min initial denaturation
at 95°C, followed by 9 cycles 30 s denaturation at 95°C,
30 s annealing at 63°C-55°C (decreasing by 1°C with every
cycle), and elongation at 72°C with an additional 25 cycles
with annealing 30 s at 58°C.
The two PCR products of each strain were mixed,
diluted to 1/500 in sterile water, and run in capillary
electrophoresis with an ABI 3730xl DNA Analyzer
(Applied Biosystems, Foster City, CA) using G5 (DS-33)
fragment analysis chemistry according to the manufac-
turer’s instructions. The GeneScan™ 600 LIZ® (Applied
Biosystems) was used as an internal size standard and
the data were analyzed using GeneMapper v4.0 software
(Applied Biosystems). MLVA types were named as a
string of six numbers showing the actual number of
repeat units in each of the six loci.
DNA sequencing
The selected repeats (Table 1) were sequenced in both
directions with MLVA primers [14]. The gyrA gene PCR
was performed for 77 sporadic Y. enterocolitica strains
of bio/serotypes 4/O:3 and 3/O:3 with primers gyrAY1
(5’-CGC GTA CTG TTT GCG ATG AA-3’) and
gyrAY2 (5’-CGG AGT CAC CAT CGA CGG AA-3’) as
earlier described (35) (GenBank/EMBL/DDBJ accession
numbers FN821873-FN821949). Sequencing was done
in both directions with a Big Dye Terminator v1.1 Cycle
Sequencing Kit (Applied Biosystems) with an ABI
3730xl DNA Analyzer (Applied Biosystems).
PGFE
PFGE was performed using the previously described pro-
tocol for Salmonella [7,37] with modifications: Strains
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were cultured overnight at 30°C on R1-agar and sus-
pended in CBS-buffer (100 mM Tris:100 MM EDTA, pH
8.0) to a final turbidity of 0.38-0.39 at A480. Lysozyme
(Roche Diagnostics GmbH, Mannheim, Germany) was
added to the 400 μl bacterial suspensions to reach a final
concentration of 1 mg/ml. The tubes were mixed and
incubated for 15 min at 37°C and then heated to 50°C,
after which 400 μl of 1% agarose (SeaKem Gold Agarose,
Cambrex Bio Science Rockland, Inc, USA) and proteinase
K (at a final concentration of 0.24 mg/ml, Roche Diagnos-
tics GmbH, Mannheim, Germany) were added. The tube
contents were cast into plugs, which were transferred into
3 ml of lysis buffer (50 mM Tris:50 mM EDTA, pH8.0 +
1% Sarcosyl) containing 1 mg/ml of proteinase K. The
plugs were incubated at 54°C for 2 h and rinsed three
times in sterile water and three times in TE buffer at 50°C.
The plugs were then stored in 1 × TE buffer at 4°C. The
released genomic DNA in the plugs was digested over-
night at 37°C with 8 U of the restriction enzyme NotI
(New England Biolabs, Ipswich, MA, USA). Electrophor-
esis was carried out in a 1% agarose gel in 0.5 × TBE buf-
fer at 14°C with a switching time of 1 to 18 s for 40 h at
14°C with CHEF Mapper system (Bio-Rad Laboratories,
Richmond, California). DNA of the Salmonella enterica
serotype Braenderup strain H9812, digested with XbaI
(Roche GmbH, Mannheim, Germany), was used as a size
marker. The PFGE types were analyzed with Bionumerics
v. 5.10 software (Applied Maths, Sint-Martens-Latem, Bel-
gium). DNA bands smaller than 54.7 kb were excluded
from the analysis.
Discriminatory index of PFGE and MLVA
Simpson’s Index of diversity was used to calculate the
discriminatory index (DI) of PFGE and MLVA [38]. In
addition, the DIs of each MLVA locus was calculated.
Susceptibility testing
The antimicrobial susceptibility of the Y. enterocolitica
isolates was determined using a set of 12 antimicrobials:
ampicillin (AMP); chloramphenicol (CHL); streptomycin
(STR); gentamicin (GEN); sulfonamide (SUL); tetracy-
cline (TET); trimethoprim (TMP); ciprofloxacin (CIP);
nalidixic acid (NAL); cefotaxime (CEF); mecillinam
(MEC); and imipenem (IMI). The susceptibility tests
were done using the agar diffusion technique on Muel-
ler-Hinton agar according to the CLSI guidelines [39].
A strain resistant to at least four antimicrobials was
called multiresistant. The minimal inhibitory concentra-
tion (MIC) for ciprofloxacin (CIP) was determined by
the E-test (AB Biodisk, Solna, Sweden) for the isolates
resistant to nalidixic acid, following the recommended
MIC breakpoints S ≤1 mg/L and R ≥4 mg/L [39]. MIC
0.125-1.0 mg/L was considered to indicate reduced sus-
ceptibility to ciprofloxacin [40].
Conjugation experiments
In conjugation experiments, the multiresistant (AMP,
CHL, STR, SUL, NAL) strain YE 4/O:3 FE81008 was
used as a donor strain and the kanamycin (KAN) resis-
tant strain YeO3-U [41] as a recipient strain. Briefly,
the donor strain and the recipient strain were grown
overnight at room temperature shaking in 5 ml of
Luria broth (LB). The cultures were refreshed by dilut-
ing them 1:10 in LB and grown for 2-3 h to get them
into the exponential phase. The donor strain was
grown in static culture. The bacteria were then pel-
leted by centrifugation and resuspended in 1 ml of
PBS. After the OD600 were determined, the suspen-
sions were mixed 1:1 and small droplets of the mixture
were pipetted onto a Luria-agar plate and incubated
overnight at room temperature. Only the donor or the
recipient bacteria was pipetted onto the control plates.
The plates were incubated overnight after which the
bacteria were collected from the plates into ca. 1 ml of
PBS. Several dilutions were spread on selective plates
containing CHL, KAN, or both CHL and KAN. The
conjugation frequency was calculated on the basis of
the proportion of CHL KAN double-resistant colonies
among the CHL-resistant colonies. The resistance of
the CHL KAN double-resistant colonies to the other
antimicrobials was tested as described above. Plasmid
isolation from 100 ml cultures of the strains was per-
formed using the E.Z.N.A plasmid midiprep kit
(Omega Bio-Tek Inc., Norcross, GA, USA) according
to the protocol provided by the manufacturer, and the
plasmids were detected by running in a 1% w/v agar-
ose gel.
Travel information and statistical method
Data on the patients’ travel abroad were collected from
the National Infectious Disease Register and from the
notes of the laboratories sending the Yersinia strains for
further typing. The association between travel and mul-
tiresistance was analyzed by using the chi-square
method with the EpiInfo™ version 3.4.3. A p-value
below 0.05 was considered to indicate statistical
significance.
The study was approved by the Ethics Committee of
National Institute for Health and Welfare, THL. For this
study informed consents were not required as only the
isolated bacterial strains of the fecal samples were stu-
died and not the individuals themselves.
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